orthopediatrics corp - KIDS

KIDS

Close Chg Chg %
20.11 -1.42 -7.06%

Closed Market

18.69

-1.42 (7.06%)

Volume: 272.77K

Last Updated:

Jan 13, 2026, 4:00 PM EDT

Company Overview: orthopediatrics corp - KIDS

KIDS Key Data

Open

$20.12

Day Range

18.43 - 20.34

52 Week Range

15.34 - 27.60

Market Cap

$504.30M

Shares Outstanding

25.08M

Public Float

16.68M

Beta

1.09

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.96

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

160.80K

 

KIDS Performance

1 Week
 
2.08%
 
1 Month
 
6.19%
 
3 Months
 
8.41%
 
1 Year
 
-31.19%
 
5 Years
 
-54.20%
 

KIDS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About orthopediatrics corp - KIDS

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.

KIDS At a Glance

OrthoPediatrics Corp.
2850 Frontier Drive
Warsaw, Indiana 46582
Phone 1-574-268-6379 Revenue 204.73M
Industry Medical Specialties Net Income -37,822,000.00
Sector Health Technology 2024 Sales Growth 37.648%
Fiscal Year-end 12 / 2025 Employees 562
View SEC Filings

KIDS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.613
Price to Book Ratio 1.583
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -51.003
Enterprise Value to Sales 2.681
Total Debt to Enterprise Value 0.154

KIDS Efficiency

Revenue/Employee 364,282.918
Income Per Employee -67,298.932
Receivables Turnover 4.833
Total Asset Turnover 0.439

KIDS Liquidity

Current Ratio 6.983
Quick Ratio 3.538
Cash Ratio 2.084

KIDS Profitability

Gross Margin 63.42
Operating Margin -14.42
Pretax Margin -20.48
Net Margin -18.474
Return on Assets -8.105
Return on Equity -10.34
Return on Total Capital -8.61
Return on Invested Capital -9.157

KIDS Capital Structure

Total Debt to Total Equity 23.887
Total Debt to Total Capital 19.281
Total Debt to Total Assets 17.51
Long-Term Debt to Equity 22.864
Long-Term Debt to Total Capital 18.456
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Orthopediatrics Corp - KIDS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
98.05M 122.29M 148.73M 204.73M
Sales Growth
+37.95% +24.72% +21.62% +37.65%
Cost of Goods Sold (COGS) incl D&A
35.33M 44.73M 54.86M 74.89M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
10.68M 13.10M 17.39M 18.76M
Depreciation
6.15M 7.12M 10.24M 10.95M
Amortization of Intangibles
4.53M 5.98M 7.15M 7.81M
COGS Growth
+47.48% +26.62% +22.66% +36.50%
Gross Income
62.72M 77.56M 93.87M 129.84M
Gross Income Growth
+33.10% +23.66% +21.02% +38.32%
Gross Profit Margin
+63.97% +63.43% +63.11% +63.42%
2021 2022 2023 2024 5-year trend
SG&A Expense
80.60M 98.97M 119.63M 159.36M
Research & Development
5.54M 8.01M 10.20M 11.03M
Other SG&A
75.06M 90.96M 109.44M 148.32M
SGA Growth
+19.93% +22.80% +20.88% +33.21%
Other Operating Expense
- - - -
-
Unusual Expense
(1.65M) (21.94M) (2.00M) 8.72M
EBIT after Unusual Expense
(16.22M) 531.00K (23.77M) (38.24M)
Non Operating Income/Expense
1.08M (1.80M) 2.46M (1.07M)
Non-Operating Interest Income
- - - 198.00K
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 2.25M 2.42M 2.62M
Interest Expense Growth
- - -34.14% +7.88%
-
Gross Interest Expense
- 2.25M 2.42M 2.62M
Interest Capitalized
- - - -
-
Pretax Income
(17.39M) (3.69M) (21.31M) (41.93M)
Pretax Income Growth
+48.35% +78.78% -477.72% -96.74%
Pretax Margin
-17.73% -3.02% -14.33% -20.48%
Income Tax
(1.13M) (4.95M) (338.00K) (4.11M)
Income Tax - Current - Domestic
- (2.95M) 85.00K (2.52M)
Income Tax - Current - Foreign
- 17.00K 740.00K 525.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
(1.13M) (2.02M) (1.16M) (2.11M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (23.00K)
-
Consolidated Net Income
(16.26M) 1.24M (20.97M) (37.82M)
Minority Interest Expense
- - - -
-
Net Income
(16.26M) 1.24M (20.97M) (37.82M)
Net Income Growth
+50.64% +107.60% -1,798.30% -80.33%
Net Margin Growth
-16.58% +1.01% -14.10% -18.47%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(16.26M) 1.24M (20.97M) (37.82M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(16.26M) 1.24M (20.97M) (37.82M)
EPS (Basic)
-0.8439 0.0596 -0.925 -1.6389
EPS (Basic) Growth
+53.75% +107.06% -1,652.01% -77.18%
Basic Shares Outstanding
19.27M 20.70M 22.68M 23.08M
EPS (Diluted)
-0.8439 0.059 -0.925 -1.6389
EPS (Diluted) Growth
+53.75% +106.99% -1,667.80% -77.18%
Diluted Shares Outstanding
19.27M 20.95M 22.68M 23.08M
EBITDA
(7.20M) (8.31M) (8.38M) (10.76M)
EBITDA Growth
+40.88% -15.51% -0.84% -28.40%
EBITDA Margin
-7.34% -6.80% -5.63% -5.26%

Snapshot

Average Recommendation BUY Average Target Price 24.125
Number of Ratings 8 Current Quarters Estimate -0.398
FY Report Date 03 / 2026 Current Year's Estimate -1.101
Last Quarter’s Earnings -0.295 Median PE on CY Estimate N/A
Year Ago Earnings -1.296 Next Fiscal Year Estimate -0.766
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate -0.40 -0.28 -1.10 -0.77
High Estimates -0.16 -0.04 -0.34 0.07
Low Estimate -0.53 -0.35 -1.40 -1.14
Coefficient of Variance -37.09 -35.85 -29.33 -51.85

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 6
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Orthopediatrics Corp in the News